DiscoverAUAUniversityLG-IR-NMIBC Treatment Landscape
LG-IR-NMIBC Treatment Landscape

LG-IR-NMIBC Treatment Landscape

Update: 2025-12-03
Share

Description

LG-IR-NMIBC Treatment Landscape

Host: Mark L. Gonzalgo, MD, PhD, MBA
Guest: Chad R. Ritch, MD, MBA, FACS

CME Available: auau.auanet.org/node/44036

ACKNOWLEDGEMENTS:
Support provided by independent educational grants from:
AstraZeneca
Johnson & Johnson

LEARNING OBJECTIVES:
At the conclusion of this activity, participants will be able to:
1. Differentiate between traditional and emerging intravesical therapies for LG-IR-NMIBC, considering mechanism of action, administration schedules, and patient eligibility to support individualized treatment planning.
2. Incorporate into practice shared decision-making strategies that align clinical recommendations with patient values, preferences, and quality-of-life considerations in the management of LG-IR-NMIBC.
3. Utilize practical approaches for integrating intravesical therapy into routine clinical workflows, including coordination among multidisciplinary teams, patient education, and follow-up to optimize adherence and outcomes.
Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

LG-IR-NMIBC Treatment Landscape

LG-IR-NMIBC Treatment Landscape

American Urological Association